The first blue laser diagnostic map of Chinese digestive physicians was officially released

Release date: 2017-09-22

On September 2, 2017, the first blue laser (BLI) diagnostic map of Chinese digestive doctors sponsored by Fujifilm (China), sponsored by China Health Promotion Foundation, "Diagnostic Atlas of Early Gastrointestinal Blue Laser Imaging Technology" Officially released at the 2017 China Digestive Endoscopy Academic Conference. The editor-in-chief of the Chinese Medical Association, Professor Zhang Yutian, deputy editor and editors of the Chinese Medical Association attended the launching ceremony and opened a new chapter in the application of blue laser technology in the field of digestive endoscopy in China.

Blue LASER Imaging (BLI) is the latest endoscopic imaging technology. Although it has not been introduced to China for a long time, it has a strong advantage in early cancer screening and intensive examination, and its image is clearer. It is easier to identify and is more helpful for doctors' diagnosis. Through the practical application and experience of blue laser technology (BLI) in clinical diagnosis, experts in the industry have developed the idea of ​​compiling maps to better apply this new endoscopic diagnosis and treatment technology to clinical work.

In addition to the technical specialities, this map has more milestones. Professor Zhang Yutian pointed out at the press conference that "most of the diagnostic maps in the past were mostly translated, and this time the Chinese digestive physician was released. My first blue laser diagnostic map. Based on Chinese domestic data, it is a collection of 101 cases and more than 1,000 pictures, which was compiled by a number of well-known domestic experts and young physicians."

Professor Zhang Yutian delivered a speech at the press conference

It is reported that the map combines the endoscopic image with the pathological image. The endoscopic performance of each case is accompanied by a detailed explanation. The endoscopic operation techniques and observation points related to early cancer diagnosis are also explained in detail. Diverse and rich, full of pictures, more targeted for Chinese doctors, can improve the level of prevention and treatment of digestive tract tumors in China and the clinical diagnosis and treatment capabilities of endoscopists, and ultimately enable patients to get better diagnosis and treatment.

At the press conference, the editor-in-chief of the Chinese Medical Association Digestive Endoscopy Professor Zhang Yutian and the Associate Editors Professor Yang Aiming, Professor Yan Ming, Professor Zhong Liang, Professor Huang Yonghui, Professor Yu Honggang, Professor Wu Qi and Fujifilm (China) Investment Co., Ltd., the vice president of Asahi Kasei, and the Minister of Endoscopy Systems, Chen Weina, jointly unveiled the map.

Later, Professor Zhang Putian presented the autographed books to the deputy editor and editor of the editorial work, thanking him for his excellent work in the limited compilation time. These endoscopic experts and pathologists sacrificed their rest time in addition to the heavy daily medical work, and repeatedly discussed in various aspects such as case selection, photo shooting, and diagnostic description, and formulated uniform standards with extremely careful and rigorous work attitude. Together, they completed the compilation of the map.

At the same time, Professor Zhang Yutian also presented books to Fujifilm (China) to attend the leadership, thanks to the equipment and technical support provided for the compilation of the map.

At the press conference, the reporter also interviewed Mr. Asahi Kazuya, Vice President of Fujifilm (China) Investment Co., Ltd., and Ms. Chen Weina, Director of Endoscopy Division, who supported the mapping activities. China) will continue to support such clinical research, promote the development of health, and at the same time make the Chinese doctor's superb technology better on the global stage.

Source: Medical Valley

PCR Reagents

PCR Reagents

Real time PCR Kit for Monkeypox Virus is used for in vitro qualitative nucleic acid detection of Monkeypox Virus in Human serum, lesion exudate samples and scab specimens. Primer sets and FAM labeled probes are designed for specific detection of Monkeypox Virus, Human RNase P gene extracted concurrently with the test sample provides an internal control to validate nucleic extraction procedure and reagent integrity. Probe targeting human RNase P gene is labeled with VIC.


Intended Use
The test is intended for in vitro qualitative detection of monkeypox virus
(MPXV) antigen in human oropharyngeal swab, whole blood or skin lesion
materials, including lesion exudate, lesion roofs, lesion crusts.
The test is used for monkeypox virus antigen test of monkeypox suspected
populations. Positive result of the antigen test can be used for early triage and
rapid management of suspected populations, but it cannot be used as
diagnosis basis of monkeypox infection. Negative results do not rule out
monkeypox infection and should not be used as the sole basis for treatment or
patient management decisions. Further nucleic acid detection should be
carried out for suspected population whose antigen test result is positive or
negative.
The test is only for professional use, not suitable for family test. The test result
is only for clinical reference and it is recommended to conduct comprehensive
analysis of the disease condition in combination with clinical manifestations of
patients and other laboratory tests.
Test Principle
According to the gold immunochromatographic test principle, the
nitrocellulose membrane is coated with MPXV mAb 2 and goat anti-mouse IgG
antibody, the gold conjugate pad is labeled with MPXV mAb 1. When the
antigen is contained in the sample, the antigen binds with the corresponding
gold labeled monoclonal antibody to form a compound, moving forward under
the chromatography, then combines with the coated antibody in the test line
to form Au-MPXV mAb 1-antigen-MPXV mAb 2 complex to condense into a red
band (Test line, T), indicating a positive result. When the sample does not
contain antigen, complex cannot be formed in the test line, and no red band
appears, indicating a negative result.
No matter whether the sample contains antigen or not, the gold labeled
monoclonal antibody will combine with the coated goat anti-mouse IgG
antibody at the control line to form a Au-MPXV mAb 1-goat anti-mouse IgG
antibody complex and condense into a red band (Control line,C)


Pcr Reagents,Reagents Used In Pcr,Reagents Required For Pcr,Pcr Reagent Kit

Changchun ZYF science and technology CO.,LTD , https://www.zyf-medical.com

Posted on